These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21387717)

  • 21. Characteristics of and current treatment options for hepatitis B and hepatitis C.
    Adams P
    J Can Dent Assoc; 2000 Nov; 66(10):537. PubMed ID: 12584770
    [No Abstract]   [Full Text] [Related]  

  • 22. [Management of chronic viral hepatitis].
    Pache I; Mondada D; Moradpour D; Fontana M
    Rev Med Suisse; 2007 Jan; 3(95):215, 217-8, 221-3. PubMed ID: 17357690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Eradication of hepatitis C virus after 3 months of interferon treatment in a patient with chronic hepatitis C].
    Winkfield B; Lunel F; Beurrier P; Calès P
    Gastroenterol Clin Biol; 2000 Jan; 24(1):136-7. PubMed ID: 10755865
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interferons and chronic hepatitis C treatment].
    Cai DC; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):847-8. PubMed ID: 18073070
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment strategies for viral hepatitis].
    Matsushima T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):133-5. PubMed ID: 11968844
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C.
    Reiser M; Hinrichsen H; Benhamou Y; Reesink HW; Wedemeyer H; Avendano C; Riba N; Yong CL; Nehmiz G; Steinmann GG
    Hepatology; 2005 Apr; 41(4):832-5. PubMed ID: 15732092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined antiviral treatment of a patient with chronic mixed hepatitis (HBV + HCV)].
    Fedorchenko SV; Martynovich TL
    Ter Arkh; 2006; 78(11):76-7. PubMed ID: 17195533
    [No Abstract]   [Full Text] [Related]  

  • 28. Current and future management of chronic hepatitis C infection.
    Cross TJ; Antoniades CG; Harrison PM
    Postgrad Med J; 2008 Apr; 84(990):172-6. PubMed ID: 18424572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral therapy for hepatitis C: why are so few patients being treated?
    Volk ML
    J Antimicrob Chemother; 2010 Jul; 65(7):1327-9. PubMed ID: 20460398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interferon treatment of chronic hepatitis C viral hepatitis patients with normal transaminases].
    Remy AJ; Blanc P
    Gastroenterol Clin Biol; 1998; 22(8-9):748-9. PubMed ID: 9823572
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic hepatitis C virus infection in children.
    Mohan N; González-Peralta RP; Fujisawa T; Chang MH; Heller S; Jara P; Kelly D; Mieli-Vergani G; Shah U; Murray KF
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):123-31. PubMed ID: 20038846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of chronic hepatitis C and molecular biology tests].
    Córdoba Cortijo J; Molina Moreno JM
    Rev Esp Quimioter; 2005 Sep; 18(3):207-9. PubMed ID: 16369661
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
    Forns Bernhardt X
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
    [No Abstract]   [Full Text] [Related]  

  • 35. Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir.
    Suzuki F; Suzuki Y; Akuta N; Sezaki H; Yatsuji H; Arase Y; Hirakawa M; Kawamura Y; Hosaka T; Kobayashi M; Saito S; Ikeda K; Kobayashi M; Watahiki S; Mineta R; Iwasaki S; Kumada H
    J Clin Virol; 2010 Jan; 47(1):76-8. PubMed ID: 19857995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Predicting factors in the efficacy of interferon treatment in chronic hepatitis C].
    Rodríguez Agulló JL
    An Med Interna; 2001 Jul; 18(7):349-50. PubMed ID: 11534417
    [No Abstract]   [Full Text] [Related]  

  • 37. Liver steatosis and antiviral therapy in chronic hepatitis C.
    Testino G; Sumberaz A
    Liver Int; 2007 Mar; 27(2):287. PubMed ID: 17311627
    [No Abstract]   [Full Text] [Related]  

  • 38. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
    Lange CM; Sarrazin C; Zeuzem S
    Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations.
    Sherman KE; Fleischer R; Laessig K; Murray J; Tauber W; Birnkrant D;
    Hepatology; 2007 Dec; 46(6):2014-20. PubMed ID: 18027878
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of chronic hepatitis C: present and future].
    Hezode C; Dhumeaux D
    Gastroenterol Clin Biol; 2000 May; 24(5):533-5. PubMed ID: 10891741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.